期刊文献+

外周血嗜酸性粒细胞对慢性阻塞性肺疾病急性加重激素治疗相关性分析 被引量:2

Correlation between Peripheral Blood Eosinophils and Hormone Therapy of Patients with AECOPD
下载PDF
导出
摘要 目的分析外周血嗜酸性粒细胞(eosimophil,EOS)与慢性阻塞性肺疾病急性加重(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者静脉应用糖皮质激素的相关性。方法选取AECOPD患者83例,分为观察组(EOS%≥2%)25例与对照组(EOS%<2%)58例。比较2组外周血EOS、EOS百分比(EOS%)、白细胞(WBC)、中性粒细胞(N)、中性粒细胞百分比(N%)、C-反应蛋白(CRP)等指标水平,采用受试者工作特征曲线(ROC曲线)评价EOS、EOS%对AECOPD患者静脉糖皮质激素应用的预测价值。结果观察组患者EOS、EOS%分别为(0.50±0.07)×109/L、(3.01±0.95)%,高于对照组的(0.20±0.09)×109/L、(1.67±0.23)%,差异有统计学意义(P<0.05)。观察组患者的WBC、N、N%、CRP、静脉激素应用时间等指标分别为(6.83±2.06)×109/L、(4.36±1.81)×109/L、(62.03±10.56)%、(8.95±2.76)mg/L及(0.48±0.07)d,小于对照组的(8.68±3.89)×109/L、(6.94±2.05)×109/L、(76.71±12.44)%、(11.45±3.90)mg/L及(2.03±0.92)d,差异均有统计学意义(P<0.05)。经ROC曲线分析,EOS%的AUC较大,为0.732(95%CI:0.621~0.844),其对应灵敏度和特异度分别为40.7%和83.0%。结论外周血EOS对于AECOPD患者的炎症评估及指导糖皮质激素抗感染治疗具有一定的临床价值。 Objective to analyze the correlation between the peripheral blood eosinophil(EOS)and intravenous glucocorticoid administration in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods A total of 83 patients with acute exacerbation of copd were selected and divided into observation group(EOS%≥2%)with 25 patients and control group(EOS<2%)with 58 patients.The level of EOS,EOS%,leukocyte(W),neutrophil(N),neutrophil percentage(N%)and C-reactive protein(CRP)were compared in each group.ROC curve was used to evaluate the predictive value of EOS and EOS%in intravenous glucocotricoid used in patients with AECOPD.Results The percentage of EOS and EOS%in observation group were(0.50±0.07)×109/L,(3.01±0.95)%,which were higher than those in control group(0.20±0.09)×109/L,(1.67±0.23)%,the difference is statistically significant(P<0.05).The indexes of W,N,N%,CPR and intravenous hormone application time in group observation were(6.83±2.06)×109/L,(4.36±1.81)×109/L,(62.03±10.56)%,(8.95±2.76)mg/L,(0.48±0.07)d respectively,and it was smaller than those in control group:(8.68±3.89)×109/L,(6.94±2.05)×109/L,(76.71±12.44)%,(11.45±3.90)mg/L,(2.03±0.92)d respectively,the difference is statistically significant(P﹤0.05).According to the analysis of ROC curve,the receiver characteristic curve AUC of EOS%is larger,0.732(95%CI:0.621~0.844),and its corresponding sensitivity and specificity are 40.7%and 83%respectively.ConclusionPeripheral blood eosinophils have a certain clinical value in the evaluation of inflammation and anti-inflammation therapy of glucocorticoid in patients with AECOPD.
作者 王慧 杨华 陈卓昌 WANG Hui;YANG Hua;CHEN Zhuochang(Department of Respiratory and Critical Care Medicine,People’s Hospital of Henan University,Henan Provincial People's Hospital,Zhengzhou Henan 450003,China)
出处 《河南医学高等专科学校学报》 2020年第2期130-133,共4页 Journal of Henan Medical College
关键词 慢性阻塞性肺疾病急性加重 外周血嗜酸性粒细胞 糖皮质激素 acute exacerbation of chronic obstructive pulmonary disease peripheral blood eosinophil glucocorticoid
  • 相关文献

二级参考文献52

  • 1俞森洋.慢性阻塞性肺病和哮喘的雾化吸入疗法[J].中国药物应用与监测,2006,3(4):28-31. 被引量:11
  • 2吴纪珍,马利军,李素云,牛红丽.慢性阻塞性肺疾病发作期与缓解期体内胶原、细胞因子变化及临床意义[J].中国实用内科杂志,2005,25(8):703-704. 被引量:37
  • 3慢性阻塞性肺疾病急性加重患者的机械通气指南(2007)[J].中国危重病急救医学,2007,19(9):513-518. 被引量:335
  • 4Rabe KF, Hurd S, Anzueto A, et al. Global strategy for thediagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007, 176: 532-555.
  • 5Slenter RH, Sprooten RT, Kotz D, et al. Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease. Respiration, 2013, 85: 15-26.
  • 6Fruehter O, Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology, 2008, 13 : 851-855.
  • 7Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration, 2012,84: 17-26.
  • 8Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med, 2013, 187 : 347-365.
  • 9Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Researh Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive disease. Thorax, 1999, 54: 581-586.
  • 10Alfageme I, Reyes N, Merino M, et al. The effect of airflow limitation on the cause of death in patients with COPD. Chron Respir Dis, 2010, 7: 135-145.

共引文献1384

同被引文献52

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部